Last 29.15 INR
Change Today -2.80 / -8.76%
Volume 1.4K
PRNX On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:18 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

parnax lab ltd (PRNX) Snapshot

Open
31.00
Previous Close
31.95
Day High
31.00
Day Low
27.00
52 Week High
06/9/14 - 61.00
52 Week Low
12/18/14 - 25.60
Market Cap
247.9M
Average Volume 10 Days
23.9K
EPS TTM
-3.29
Shares Outstanding
8.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PARNAX LAB LTD (PRNX)

Related News

No related news articles were found.

parnax lab ltd (PRNX) Related Businessweek News

No Related Businessweek News Found

parnax lab ltd (PRNX) Details

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India. It offers liquid orals, ointments, and external powders. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. Parnax Lab Limited was incorporated in 1982 and is based in Mumbai, India.

Founded in 1982

parnax lab ltd (PRNX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

parnax lab ltd (PRNX) Key Developments

Parnax Lab Limited to Report Q2, 2015 Results on Nov 14, 2014

Parnax Lab Limited announced that they will report Q2, 2015 results on Nov 14, 2014

Parnax Lab Limited, Board Meeting, Nov 14, 2014

Parnax Lab Limited, Board Meeting, Nov 14, 2014. Agenda: To consider the proposal of approval of un-audited financial results for the quarter and half year ended September 30, 2014; to consider the proposal for approval of assets and liabilities statement for half year ended September 30, 2014; and to discuss on preferential issue of equity shares/ warrants towards raising of additional capital to the extent of INR 250 million by the company pursuant to Section 62 of the Companies Act, 2013 and as per SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009.

Parnax Lab Limited Reports Unaudited Standalone and Consolidated Earnings Results for the First Quarter Ended June 30, 2014

Parnax Lab Limited reported unaudited standalone and consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 28.558 million against INR 37.479 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 8.314 million against Profit from operations before other income, finance costs and exceptional items of INR 0.364 million a year ago. Loss from ordinary activities before tax was INR 12.502 million against INR 2.677 million a year ago. Net loss for the period was INR 12.502 million or INR 1.47 per basic and diluted share against INR 2.677 million or INR 0.31 per basic and diluted share a year ago. For the quarter, on consolidated basis, the group reported net sales/income from operations of INR 211.9 million against INR 120.05 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 19.319 million against INR 20.164 million a year ago. Profit from ordinary activities before tax was INR 8.984 million against INR 12.380 million a year ago. Net profit for the period was INR 8.984 million or INR 1.05 per basic and diluted share against net profit for the period of INR 12.380 million or INR 1.45 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRNX:IN 29.15 INR -2.80

PRNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRNX.
View Industry Companies
 

Industry Analysis

PRNX

Industry Average

Valuation PRNX Industry Range
Price/Earnings 12.0x
Price/Sales 0.3x
Price/Book 1.2x
Price/Cash Flow 5.9x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PARNAX LAB LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.